
Concentrix (CNXC) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Feb 2025Income Metrics
Revenue
2.4B
Gross Profit
855.9M
36.08%
Operating Income
168.9M
7.12%
Net Income
70.3M
2.96%
EPS (Diluted)
$1.04
Balance Sheet Metrics
Total Assets
11.9B
Total Liabilities
7.9B
Shareholders Equity
4.0B
Debt to Equity
1.95
Cash Flow Metrics
Operating Cash Flow
231.1M
Free Cash Flow
180.7M
Revenue & Profitability Trend
Concentrix Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 9.6B | 7.1B | 6.3B | 5.6B | 4.7B |
Cost of Goods Sold | 6.2B | 4.5B | 4.1B | 3.6B | 3.1B |
Gross Profit | 3.4B | 2.6B | 2.3B | 2.0B | 1.7B |
Gross Margin % | 35.9% | 36.2% | 35.7% | 35.3% | 35.2% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 2.9B | 1.9B | 1.6B | 1.4B | 1.4B |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 2.9B | 1.9B | 1.6B | 1.4B | 1.4B |
Operating Income | 596.4M | 661.3M | 640.2M | 572.4M | 308.8M |
Operating Margin % | 6.2% | 9.3% | 10.1% | 10.2% | 6.5% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 321.8M | 201.0M | 70.1M | 23.0M | 48.3M |
Other Non-Operating Income | 24.7M | -52.1M | 34.9M | 6.3M | 7.4M |
Pre-tax Income | 299.3M | 408.2M | 605.0M | 555.7M | 267.9M |
Income Tax | 48.1M | 94.4M | 169.4M | 150.1M | 103.1M |
Effective Tax Rate % | 16.1% | 23.1% | 28.0% | 27.0% | 38.5% |
Net Income | 251.2M | 313.8M | 435.6M | 405.6M | 164.8M |
Net Margin % | 2.6% | 4.4% | 6.9% | 7.3% | 3.5% |
Key Metrics | |||||
EBITDA | 1.3B | 997.5M | 984.6M | 855.9M | 592.8M |
EPS (Basic) | $3.72 | $5.72 | $8.34 | $7.78 | $3.19 |
EPS (Diluted) | $3.71 | $5.70 | $8.28 | $7.70 | $3.19 |
Basic Shares Outstanding | 64977000 | 53801000 | 51353000 | 51355000 | 51602000 |
Diluted Shares Outstanding | 64977000 | 53801000 | 51353000 | 51355000 | 51602000 |
Income Statement Trend
Concentrix Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 240.6M | 295.3M | 145.4M | 182.0M | 152.7M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 1.1B | 1.1B | 782.0M | 714.0M | 644.8M |
Inventory | - | - | - | - | - |
Other Current Assets | 486.1M | 453.3M | 206.4M | 152.1M | 185.5M |
Total Current Assets | 2.8B | 2.9B | 1.8B | 1.5B | 1.4B |
Non-Current Assets | |||||
Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 |
Goodwill | 12.3B | 13.0B | 6.8B | 4.3B | 4.5B |
Intangible Assets | 2.3B | 2.8B | 985.6M | 655.5M | 799.0M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 1.2B | 1.0B | 621.6M | 627.1M | 667.5M |
Total Non-Current Assets | 9.1B | 9.6B | 4.9B | 3.5B | 3.8B |
Total Assets | 12.0B | 12.5B | 6.7B | 5.0B | 5.2B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 209.8M | 243.6M | 161.2M | 129.4M | 140.6M |
Short-term Debt | 2.5M | 2.3M | - | - | 33.8M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 2.0B | 2.1B | 1.1B | 968.2M | 1.0B |
Non-Current Liabilities | |||||
Long-term Debt | 4.7B | 4.9B | 2.2B | 802.0M | 1.1B |
Deferred Tax Liabilities | 312.6M | 414.2M | 105.5M | 109.5M | 153.6M |
Other Non-Current Liabilities | 910.3M | 920.5M | 512.0M | 546.4M | 601.9M |
Total Non-Current Liabilities | 6.0B | 6.3B | 2.8B | 1.5B | 1.9B |
Total Liabilities | 8.0B | 8.3B | 4.0B | 2.4B | 2.9B |
Equity | |||||
Common Stock | 7.0K | 7.0K | 5.0K | 5.0K | 0 |
Retained Earnings | 1.2B | 1.0B | 774.1M | 392.5M | 0 |
Treasury Stock | 421.4M | 272.0M | 190.8M | 57.5M | 0 |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 4.0B | 4.1B | 2.7B | 2.6B | 2.3B |
Key Metrics | |||||
Total Debt | 4.7B | 4.9B | 2.2B | 802.0M | 1.1B |
Working Capital | 846.6M | 784.6M | 622.2M | 574.9M | 414.7M |
Balance Sheet Composition
Concentrix Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 251.2M | 313.8M | 435.6M | 405.6M | 164.8M |
Depreciation & Amortization | 705.8M | 388.3M | 309.5M | 277.2M | 276.6M |
Stock-Based Compensation | 96.1M | 62.1M | 47.1M | 36.2M | 15.6M |
Working Capital Changes | -166.9M | -10.7M | -163.4M | -143.1M | 33.3M |
Operating Cash Flow | 648.8M | 654.0M | 600.4M | 551.8M | 489.6M |
Investing Activities | |||||
Capital Expenditures | -238.8M | -180.5M | -140.0M | -149.1M | -171.3M |
Acquisitions | -5.5M | -1.9B | -1.7B | 70.4M | -5.6M |
Investment Purchases | - | - | - | - | 0 |
Investment Sales | - | - | - | - | 0 |
Investing Cash Flow | -244.3M | -2.1B | -1.8B | -78.6M | -109.2M |
Financing Activities | |||||
Share Repurchases | -149.5M | -81.2M | -133.3M | -57.5M | 0 |
Dividends Paid | -83.8M | -63.5M | -53.4M | -13.1M | 0 |
Debt Issuance | 2.2B | 4.4B | 3.9B | 1.3B | 1.2B |
Debt Repayment | -2.4B | -2.4B | -2.5B | -1.7B | -1.5B |
Financing Cash Flow | -497.6M | 1.8B | 1.2B | -415.6M | -1.8B |
Free Cash Flow | 428.7M | 497.5M | 460.7M | 365.1M | 336.3M |
Net Change in Cash | -93.0M | 340.2M | -10.0M | 57.6M | -1.4B |
Cash Flow Trend
Concentrix Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
12.99
Forward P/E
3.85
Price to Book
0.70
Price to Sales
0.31
PEG Ratio
-0.36
Profitability Ratios
Profit Margin
2.54%
Operating Margin
6.83%
Return on Equity
5.85%
Return on Assets
3.78%
Financial Health
Current Ratio
1.61
Debt to Equity
135.96
Beta
0.58
Per Share Data
EPS (TTM)
$3.65
Book Value per Share
$67.99
Revenue per Share
$150.18
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
cnxc | 3.0B | 12.99 | 0.70 | 5.85% | 2.54% | 135.96 |
International | 224.8B | 38.92 | 8.17 | 22.67% | 9.11% | 245.47 |
Accenture plc | 157.9B | 20.17 | 5.17 | 26.93% | 11.61% | 25.88 |
Epam Systems | 9.3B | 23.93 | 2.54 | 11.35% | 7.91% | 4.44 |
Parsons | 8.4B | 35.27 | 3.34 | 12.44% | 3.70% | 56.60 |
Genpact | 7.6B | 14.51 | 2.94 | 21.86% | 10.92% | 59.21 |
Financial data is updated regularly. All figures are in the company's reporting currency.